Early-onset neonatal group B streptococcal infection: implications for practice

D K Parks1, R J Yetman, V Moyer

  • 1Medical School Health Services, University of Texas-Houston Medical School 77030, USA.

Insights

Group B Streptococcus (GBS) causes significant newborn illness and death. Improved prevention strategies are needed, as current methods are inconsistently applied, failing to reduce GBS disease rates in neonates.

Area of Science:

  • Neonatal infectious diseases
  • Bacterial pathogenesis
  • Public health interventions

Background:

  • Group B Streptococcus (GBS) is a primary cause of neonatal morbidity and mortality in the US.
  • Intrapartum antimicrobial prophylaxis can prevent most GBS neonatal infections in high-risk mothers.
  • Current GBS prevention strategies lack consistent implementation, hindering a decline in neonatal GBS disease incidence.

Purpose of the Study:

  • To underscore the importance of understanding GBS epidemiology and clinical presentation for neonatal care.
  • To highlight the need for enhanced decision-making skills among PNPs regarding GBS prevention.
  • To equip PNPs to evaluate and compare emerging GBS prevention strategies.

Main Methods:

  • Review of GBS epidemiology and clinical presentation.
  • Analysis of current intrapartum antimicrobial prophylaxis guidelines and their limitations.
  • Evaluation of factors influencing the consistent implementation of prevention strategies.

Main Results:

  • Despite available prevention methods, neonatal GBS disease incidence remains a significant concern.
  • Inconsistent application of prophylaxis protocols contributes to the lack of decline in GBS infections.
  • Enhanced understanding of GBS is crucial for effective clinical management.

Conclusions:

  • Effective GBS prevention requires consistent application of evidence-based strategies.
  • PNPs play a critical role in managing and preventing neonatal GBS infections.
  • Further research and improved implementation are necessary to reduce the burden of neonatal GBS disease.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...